### Background Research for the Article
**Prof. Dr. Petra Kleinbongard: Overview**
Prof. Dr. Petra Kleinbongard is a prominent scientist in the field of biology and medicine, with a particular focus on cardiovascular health. Her expertise lies in pathophysiology, which examines how disease processes affect bodily functions, particularly related to the heart and circulatory system.
**Education and Career Milestones**
– **Academic Background:** Prof. Kleinbongard holds advanced degrees in biology, equipping her with a strong foundation for her research.
– **Current Position:** She has been serving as the Deputy Director at the Institute of Pathophysiology at the Medical Faculty of Duisburg-Essen University since 2020.
– **Leadership Role:** Under her leadership, she heads the Department of Cardioprotection, where she focuses on researching methods to protect heart tissue from injury or damage.
**Adjunct Professorship at MedUni Wien**
Being named an „Adjunct Professor“ at MedUni Wien (Medical University of Vienna) is a significant recognition in academia that acknowledges Prof. Kleinbongard’s contribution to medical research and education.
### FAQ for the Article
1. **What does it mean to be appointed as an Adjunct Professor?**
– An Adjunct Professorship is usually awarded to individuals who have notable achievements and contributions within their field but may not be full-time faculty members at that institution. It allows experts from different institutions to collaborate with universities while enriching academic programs.
2. **Where does Prof. Dr. Petra Kleinbongard currently work?**
– She is currently working as Deputy Director at the Institute for Pathophysiology at Duisburg-Essen University’s Medical Faculty and serves as Head of Cardioprotection Department there.
3. **What area of research does Prof. Dr. Kleinbongard specialize in?**
– Her specialization lies within pathophysiology related to cardiovascular health—essentially how diseases affect heart function—and she actively researches ways to protect heart tissues from various types of damage.
4. **Why is her appointment significant?**
– The appointment highlights international collaboration between leading medical institutions and recognizes outstanding contributions made by researchers like Prof.Kleinbongard toward advancing medical science, particularly concerning heart health.
5. **How does this appointment benefit med students or patients?**
– For students, having access to renowned educators like Prof.Kleinbongard enhances their learning experience through exposure to cutting-edge research practices; patients benefit indirectly when such collaborations lead to new discoveries or treatments that improve healthcare outcomes.
6. **What are some possible implications of her ongoing research on cardioprotection?**
– Ongoing studies may lead toward innovative treatments or preventive measures against common cardiovascular ailments such as heart attacks or strokes by understanding protective mechanisms against cardiac injuries better.
7..**Is there any specific project she will focus on during this role?**
– While details about specific projects aren’t mentioned, it can be expected that collaborations between MedUni Wien colleagues might focus broadly on cardiac health improvements given both institutes‘ commitment towards study innovations surrounding these issues.
8..**How can we find more information about recent developments from her work?***
-*Additional updates regarding developments coming from either institution can often be found via professional networks they maintain online (e.g., university press releases), academic publications listings allowing accessible access into leading breakthroughs generated by established personnel.*
—
I created an informative background contextualizing Prof.Dr.Petra’s accomplishments while providing key FAQs derived logically stemming off presented article content! Please reach out if needing further elaboration around this matter!
Originamitteilung:
Prof. Dr. Petra Kleinbongard wurde als „Adjunct Professor“ an die Medizinischen Fakultät der Universität Wien berufen. Die 51-jährige Biologin ist seit 2020 stellvertretende Direktorin des Instituts für Pathophysiologie an der Medizinischen Fakultät der Universität Duisburg-Essen und des Universitätsklinikums Essen und leitet die Abteilung für Kardioprotektion.